BioWorld MedTech

Aug. 29, 2012

Aesthetics is going strong while orthopedics struggles

German valve registry reveals real-world TAVI experience

MUNICH, Germany — Minimally invasive aortic valve replacement accounted for 28% of procedures in Germany in 2011, the year following approval of the procedure for reimbursement. Read More

PROTECT trial vindicates DES for long-term benefits

GE Healthcare's Discovery well suited for Hybrid OR

Medtronic reports results from Symplicity HTN-2 trial

Deals roundup: MM to acquire Ascender for undisclosed amount

Court Report: Medtronic expands patent lawsuit against Nuvasive

Med-Tech Notes

Agreements/contracts: PerkinElmer works with Mass Gen on sequencing

HIT roundup: EHNAC set to discuss PHI protection in upcoming webinar

Financings roundup: Nextremity closes $6.6M; opens first preferred round

People in the News

Product Briefs

Medgenics board member Brukardt dies at age 66

MDD's Oncology Extra

Today's news in brief

BioWorld

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...